---
schema_version: "secwatch.filing_event.v1"
accession: "0001555280-25-000201"
form_type: "8-K"
ticker: "ZTS"
cik: "0001555280"
company_name: "Zoetis Inc."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T11:46:13.470025+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Zoetis Q1 2025 revenue $2.2B (+9% organic), adj EPS $1.48; affirms 6-8% organic growth for FY

## Summary
- Revenue $2.2B (+1% reported, +9% organic operational); net income $631M, diluted EPS $1.41.
- Adjusted net income $662M, adj diluted EPS $1.48; +6% organic operational growth YoY.
- U.S. segment revenue $1.2B (+6% organic); International $1.0B (+11% organic on operational basis).
- FY25 guidance: revenue $9.425-9.575B (6-8% organic); adj diluted EPS $6.20-6.30, reflecting FX and tariffs.
- Simparica Trio gains U.S. flea tapeworm label; avian influenza vaccine conditional license in U.S./Canada.

## SEC filing metadata
- accession: 0001555280-25-000201
- form_type: 8-K
- ticker: ZTS
- cik: 0001555280
- company_name: Zoetis Inc.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555280/000155528025000201/0001555280-25-000201-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555280/000155528025000201/zts-20250506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001555280-25-000201
- JSON: https://secwatch.observer/filing/0001555280-25-000201.json
- Plain text: https://secwatch.observer/filing/0001555280-25-000201.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.